With over 20 years experience in clinical drug development in a variety of therapeutic areas including virology and oncology, Phillipa Graham has been involved in significant projects ranging from writing clinical development plans, protocol design, drafting amendments, medical monitoring and safety data review. As an independent pharmaceutical physician with Bexon Clinical, her main areas of expertise are in Phase I to Phase IV clinical development plans and in all aspects of the development cycle of a new drug. Dr. Graham has worked with both start-up biotechnology firms and major pharmaceutical companies. She completed her MBchB (equivalent to an MD) at the University of Leeds in the United Kingdom.